| scholarly article | Q13442814 |
| P2093 | author name string | C A Stockmeier | |
| D C Perry | |||
| K J Kellar | |||
| M I Dávila-García | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1545-1552 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies | |
| P478 | volume | 289 |
| Q34109947 | 86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization |
| Q92726922 | A fractionated analysis of hot and cool self-regulation in cigarette smokers from different socioeconomic backgrounds |
| Q37337365 | A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder |
| Q38256359 | Acetylcholine release and inhibitory interneuron activity in hippocampal CA1. |
| Q35383876 | Acetylcholine release in mouse hippocampal CA1 preferentially activates inhibitory-selective interneurons via α4β2* nicotinic receptor activation |
| Q37707730 | Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors |
| Q36469337 | Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT. |
| Q35978097 | Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors. |
| Q33831724 | Alterations in cholinergic sensitivity of respiratory neurons induced by pre-natal nicotine: a mechanism for respiratory dysfunction in neonatal mice |
| Q44699098 | Assembly of alpha4beta2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. |
| Q30488629 | Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning |
| Q37381476 | Baseline impulsive choice predicts the effects of nicotine and nicotine withdrawal on impulsivity in rats. |
| Q36103496 | Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning |
| Q41868614 | CHRNA4 and ANKK1 Polymorphisms Influence Smoking-Induced Nicotinic Acetylcholine Receptor Upregulation |
| Q33924248 | Choline promotes nicotinic receptor alpha4 + beta2 up-regulation |
| Q48787345 | Cholinergic control in developing prefrontal-hippocampal networks. |
| Q40821290 | Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function. |
| Q36465049 | Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism |
| Q35209160 | Chronic nicotine pretreatment is sufficient to upregulate α4* nicotinic receptors and increase oral nicotine self-administration in mice |
| Q37454529 | Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. |
| Q46006435 | Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test. |
| Q36335508 | Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain. |
| Q37722609 | Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain |
| Q36304857 | Chronic treatment with varenicline changes expression of four nAChR binding sites in mice |
| Q35181132 | Contributions of β2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility in mice |
| Q26744123 | Crucial roles of the CHRNB3-CHRNA6 gene cluster on chromosome 8 in nicotine dependence: update and subjects for future research |
| Q36283969 | Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism |
| Q46587041 | Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation |
| Q35073748 | Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure |
| Q37995815 | Development of the motivational system during adolescence, and its sensitivity to disruption by nicotine. |
| Q64928689 | Differences in Nicotine Encoding Dopamine Release between the Striatum and Shell Portion of the Nucleus Accumbens. |
| Q89122894 | Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of α4β2* nAChRs in Wistar male rats |
| Q35080227 | Differential expression of arc mRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain |
| Q34540821 | Down-regulation of Decapping Protein 2 mediates chronic nicotine exposure-induced locomotor hyperactivity in Drosophila |
| Q55171928 | Effect of traumatic brain injury on nicotine-induced modulation of dopamine release in the striatum and nucleus accumbens shell. |
| Q57789499 | Effects of Acute and Chronic Nicotine on Catecholamine Neurons of the Nucleus of the Solitary Tract |
| Q33855077 | Effects of adolescent nicotine exposure and withdrawal on intravenous cocaine self-administration during adulthood in male C57BL/6J mice |
| Q35209455 | Effects of chronic nicotine on heteromeric neuronal nicotinic receptors in rat primary cultured neurons |
| Q35562759 | Endogenously expressed muscarinic receptors in HEK293 cells augment up-regulation of stably expressed α4β2 nicotinic receptors |
| Q21195727 | Evaluation of 18F-nifene binding to α4β2 nicotinic receptors in the rat brain using microPET imaging |
| Q31754077 | Galantamine: a review of its use in Alzheimer's disease |
| Q35080147 | Gene x disease interaction on orbitofrontal gray matter in cocaine addiction |
| Q26853457 | Genetic matters: thirty years of progress using mouse models in nicotinic research |
| Q30491854 | Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction |
| Q38632734 | Granulocytes as models for human protein marker identification following nicotine exposure |
| Q36560437 | Guidelines on nicotine dose selection for in vivo research. |
| Q48439102 | Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. |
| Q36840066 | Impact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primates |
| Q36779488 | Impact of sustained exposure to β-amyloid on calcium homeostasis and neuronal integrity in model nerve cell system expressing α4β2 nicotinic acetylcholine receptors |
| Q34715683 | Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain |
| Q27010347 | Inside-out neuropharmacology of nicotinic drugs |
| Q35694111 | Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies |
| Q36666651 | It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood |
| Q37260321 | Layer-specific cholinergic control of human and mouse cortical synaptic plasticity |
| Q43662839 | Long-lasting enhancement of glutamatergic synaptic transmission by acetylcholine contrasts with response adaptation after exposure to low-level nicotine. |
| Q36955591 | Long-term upregulation of protein kinase A and adenylate cyclase levels in human smokers. |
| Q24647069 | Mammalian nicotinic acetylcholine receptors: from structure to function |
| Q40819683 | Manipulation of Subunit Stoichiometry in Heteromeric Membrane Proteins |
| Q28509139 | Mechanisms of inhibition and potentiation of α4β2 nicotinic acetylcholine receptors by members of the Ly6 protein family |
| Q92736488 | Mitochondria as a possible target for nicotine action |
| Q90603824 | More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder |
| Q35185264 | Naturally-expressed nicotinic acetylcholine receptor subtypes |
| Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
| Q36363825 | Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits |
| Q36203479 | Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking |
| Q24632647 | Nicotine chemistry, metabolism, kinetics and biomarkers |
| Q37413060 | Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. |
| Q35777580 | Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms |
| Q37525085 | Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction |
| Q39375182 | Nicotinic acetylcholine receptor expression and susceptibility to cholinergic immunomodulation in human monocytes of smoking individuals. |
| Q26782271 | Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use |
| Q35381846 | Nicotinic excitatory postsynaptic potentials in hippocampal CA1 interneurons are predominantly mediated by nicotinic receptors that contain α4 and β2 subunits |
| Q36564840 | Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms |
| Q48587669 | Nicotinic receptor blockade decreases fos immunoreactivity within orexin/hypocretin-expressing neurons of nicotine-exposed rats. |
| Q36882136 | Nicotinic receptors as CNS targets for Parkinson's disease |
| Q48582261 | Orbitofrontal participation in sign- and goal-tracking conditioned responses: Effects of nicotine |
| Q34291685 | PET imaging of α4β2* nicotinic acetylcholine receptors: quantitative analysis of 18F-nifene kinetics in the nonhuman primate. |
| Q34406363 | Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline |
| Q38193225 | Pharmacological chaperoning of nAChRs: a therapeutic target for Parkinson's disease. |
| Q49977148 | Pharmacological intervention and abstinence in smokers undergoing cessation treatment: A psychophysiological study. |
| Q36158842 | Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders |
| Q37093972 | Prenatal nicotine exposure enhances the trigeminocardiac reflex via serotonin receptor facilitation in brainstem pathways |
| Q93147172 | Prevalence and analysis of tobacco use disorder in patients diagnosed with lung cancer |
| Q42220091 | Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors |
| Q34630295 | Protein kinases and addiction. |
| Q34668336 | RIC-3 differentially modulates α4β2 and α7 nicotinic receptor assembly, expression, and nicotine-induced receptor upregulation |
| Q48324217 | Reduced α4 subunit expression in α4+- and α4+- /β2+- nicotinic acetylcholine receptors alters α4β2 subtype up-regulation following chronic nicotine treatment. |
| Q36105397 | Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures |
| Q36337926 | Regulation of α4β2α5 nicotinic acetylcholinergic receptors in rat cerebral cortex in early and late adolescence: Sex differences in response to chronic nicotine |
| Q35139659 | Regulatory strategies to reduce tobacco addiction in youth |
| Q37024161 | Review. Neurobiology of nicotine dependence |
| Q35690145 | Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders |
| Q49263953 | Scientific Evidence for the Addictiveness of Tobacco and Smoking Cessation in Tobacco Litigation |
| Q41283764 | Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation. |
| Q58575281 | Serine residues in the α4 nicotinic acetylcholine receptor subunit regulate surface α4β2* receptor expression and clustering |
| Q24606315 | Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers |
| Q37397312 | Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers |
| Q34164290 | Spectral confocal imaging of fluorescently tagged nicotinic receptors in knock-in mice with chronic nicotine administration |
| Q37916643 | Targeting nicotinic receptors for Parkinson's disease therapy |
| Q38697522 | The (α4)3(β2)2 Stoichiometry of the Nicotinic Acetylcholine Receptor Predominates in the Rat Motor Cortex. |
| Q37601909 | The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain. |
| Q26821785 | The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function |
| Q35236613 | The possible contribution of neuronal nicotinic acetylcholine receptors in depression |
| Q35964545 | Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy |
| Q36650308 | Tobacco smoke exposure induces nicotine dependence in rats |
| Q37520911 | Treating tobacco dependence in a medical setting |
| Q42849105 | Update on smoking cessation techniques. |
| Q37195457 | Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice |
| Q33551855 | beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking |
| Q35264378 | α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease |
| Q42743728 | α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration. |
Search more.